Clinics begin adopting Genetic Technologies risk test

2022 04 18 13 42 3384 Dna Genome Gene Targeted 400

Genetic Technologies said Friday it has started implementing its geneType Risk Assessment Test at 16 medical practices across the Australian east coast.

The clinics can focus on testing for a single disease or multiple diseases, including breast cancer, colorectal cancer, ovarian cancer, coronary artery disease, prostate cancer, and type 2 diabetes, the company said.

It added that its geneType Hub strategy focuses on establishing centers of excellence and the routine use of geneType Risk Assessment Tests in clinics for appropriate patients.

Page 1 of 1